Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis
Status:
Unknown status
Trial end date:
2019-10-30
Target enrollment:
Participant gender:
Summary
This is a multi-regional, randomized, double-blind, placebo-controlled, clinical trial to
evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of SHR-1314 in adults
with moderate-to-severe plaque psoriasis.